 |
市场调查报告书
商品编码
1629636
经导管主动脉瓣置换术市场依手术类型、设备类型、最终用户和地区划分Transcatheter Aortic Valve Replacement Market, By Procedure Type, By Device Type, By End User, By Geography |
||||||
2024 年全球经导管主动脉瓣置换术市场规模估计为 67.1 亿美元，预计到 2031 年将达到 108 亿美元，2024 年至 2031 年的复合年增长率为 7%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2023 | 2024 年的市场规模 | 67.1亿美元 |
| 效能资料 | 2019 年至 2023 年 | 预测期 | 2024 年至 2031 年 |
| 预测期间 2024 年至 2031 年复合年增长率： | 7.00％ | 2031 年价值预测 | 108亿美元 |
过去十年，受全球老年人口不断增长和主动脉瓣狭窄盛行率不断上升的推动，全球经导管主动脉瓣置换术术市场迅速成长。 TAVR 手术为患有严重主动脉瓣狭窄且接受开胸手术风险较高的患者提供了一种微创治疗选择。在此过程中，透过导管插入折迭式的人工心臟瓣膜，并将其放置在患病的原生主动脉瓣内。这种方法降低了与开胸手术相关的风险，例如严重出血、感染疾病和长期住院。随着越来越多的临床证据证明 TAVR 的安全性、有效性和持久性，患者的合格标准正在扩大，推动其在北美等主要地区的市场更广泛的应用。广泛的技术进步和新产品的核准，特别是在瓣膜输送系统方面，也有助于推动 TAVR 在全球的普及。
市场动态：
全球经导管主动脉瓣置换术术市场的发展主要受到老年人口快速成长的推动，老年人口更容易罹患主动脉瓣狭窄。全球范围内预期寿命的增加和人口老化导致需要心臟瓣膜置换术的患者数量显着增加。 2024年10月，世界卫生组织估计，全球60岁及以上人口预计将在2015年至2050年间翻一番，从12％达到22％。心血管疾病负担的不断加重和人们对微创手术的认识的不断提高进一步推动了经导管主动脉瓣置换术的普及。与开胸心臟手术相比，经导管手术更受青睐，因为其恢復时间更短、住院时间更短，且併发症风险更低，尤其是对于高风险患者而言。然而，在大多数人口无法获得先进心臟治疗的新兴国家，经导管主动脉瓣置换术的市场发展潜力仍未开发。
本研究的主要特点
本研究报告对全球经导管主动脉置换术市场进行了详细分析，并提供了预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2023 年。
它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
全球经导管主动脉瓣置换术市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
研究中涉及的主要企业包括 Edwards Lifesciences Corp.、Medtronic Plc.、Abbott Laboratories.、Boston Scientific Corp.、MicroPort Scientific Corp.、JenaValve Technology GmbH.、Cardiovascular Systems, Inc.、Symetis SA.、Leet Medical Co.Ltd.、Tebburea. 、Biotronik SE &Co.KG. 和 Cook Medical。
本报告提供的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球经导管主动脉瓣置换术市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球经导管主动脉瓣置换术市场的各种策略矩阵来促进决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要进展
- 监管情景
- 产品发布/核准
- PEST分析
- PORTER 分析
- 併购情景
- 产业趋势
4. 全球经导管主动脉瓣置换术市场，依手术类型，2019 年至 2031 年
- 经股动脉
- 山顶
- 其他方法
5. 全球经导管主动脉瓣置换术市场，依设备类型，2019 年至 2031 年
- 气囊膨胀阀
- 自膨胀瓣膜
6. 全球经导管主动脉瓣置换术市场，依最终用户划分，2019 年至 2031 年
- 医院
- 门诊手术中心
- 独立的心臟导管室
- 其他的
7. 2019 年至 2031 年全球经导管主动脉瓣置换术市场（按地区）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第八章 竞争格局
- Edwards Lifesciences Corp.
- Medtronic Plc.
- Abbott Laboratories.
- Boston Scientific Corp.
- MicroPort Scientific Corp.
- JenaValve Technology GmbH.
- Cardiovascular Systems, Inc.
- Symetis SA.
- Lepu Medical Technology Co., Ltd.
- Terumo Corporation.
- Jude Medical（now part of Abbott）.
- AtriCure, Inc.
- Vascular Solutions, Inc.
- Biotronik SE & Co. KG.
- Cook Medical
第 9 章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
The global transcatheter aortic valve replacement market is estimated to be valued at USD 6.71 Bn in 2024 and is expected to reach USD 10.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 6.71 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 7.00% | 2031 Value Projection: | US$ 10.80 Bn |
The global transcatheter aortic valve replacement market has been growing rapidly over the past decade backed by the rising geriatric population and increasing prevalence of aortic stenosis globally. TAVR procedures offer a minimally invasive treatment option for severe aortic stenosis patients who are at high risk for open-heart surgeries. The technique involves threading a collapsible prosthetic heart valve through a catheter into the body and placing it inside the diseased native aortic valve. This method reduces risks associated with open-heart surgeries such as severe bleeding, infections, and long hospital recovery times. As more clinical evidence demonstrates the safety, efficacy, and longevity of TAVR patient eligibility criteria have expanded, driving wider market adoption in key regions such as North America. Widespread technological advancements especially around valve delivery systems and new product approvals too have boosted the uptake of TAVR globally.
Market Dynamics:
The global transcatheter aortic valve replacement market is primarily driven by the rapidly growing geriatric population base that is more susceptible to aortic stenosis. Rising life expectancy and aging demographics worldwide have significantly upscaled the patient pool requiring heart valve replacements. In October 2024, as per the WHO estimates, the global population aged 60 years and over is projected to double from 12% to 22% between 2015 and 2050. Growing burden of cardiovascular diseases and increasing awareness about minimally invasive procedures have further propelled the adoption of transcatheter aortic valve replacement. Transcatheter approaches are preferred over open-heart surgeries since they offer shortened recovery times, reduced hospital stays, and lower complication risks, especially for high-risk patients. However, the market potential of transcatheter aortic valve replacement is still untapped in developing nations where a majority population lacks access to advanced cardiac care.
Key Features of the Study:
This report provides in-depth analysis of the global transcatheter aortic valve replacement market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global transcatheter aortic valve replacement market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Edwards Lifesciences Corp., Medtronic Plc., Abbott Laboratories., Boston Scientific Corp., MicroPort Scientific Corp., JenaValve Technology GmbH., Cardiovascular Systems, Inc., Symetis SA., Lepu Medical Technology Co., Ltd., Terumo Corporation., St. Jude Medical (now part of Abbott)., AtriCure, Inc., Vascular Solutions, Inc., Biotronik SE & Co. KG., and Cook Medical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global transcatheter aortic valve replacement market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transcatheter aortic valve replacement market
Market Segmentation
- By Procedure Type Insights (Revenue, USD Bn, 2019 - 2031)
- Transfemoral
- Transapical
- Other Approaches
- By Device Type Insights (Revenue, USD Bn, 2019 - 2031)
- Balloon-Expandable Valves
- Self-Expanding Valves
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Ambulatory Surgical Centers
- Independent Cardiac Catheterization Labs
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Edwards Lifesciences Corp.
- Medtronic Plc.
- Abbott Laboratories.
- Boston Scientific Corp.
- MicroPort Scientific Corp.
- JenaValve Technology GmbH.
- Cardiovascular Systems, Inc.
- Symetis SA.
- Lepu Medical Technology Co., Ltd.
- Terumo Corporation.
- Jude Medical (now part of Abbott).
- AtriCure, Inc.
- Vascular Solutions, Inc.
- Biotronik SE & Co. KG.
- Cook Medical
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Transcatheter Aortic Valve Replacement Market, By Procedure Type
- Global Transcatheter Aortic Valve Replacement Market, By Device Type
- Global Transcatheter Aortic Valve Replacement Market, By End User
- Global Transcatheter Aortic Valve Replacement Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Transcatheter Aortic Valve Replacement Market, By Procedure Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Transfemoral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Transapical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other Approaches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Transcatheter Aortic Valve Replacement Market, By Device Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Balloon-Expandable Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Self-Expanding Valves
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Transcatheter Aortic Valve Replacement Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Independent Cardiac Catheterization Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Transcatheter Aortic Valve Replacement Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country /Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Edwards Lifesciences Corp.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic Plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corp.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MicroPort Scientific Corp.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- JenaValve Technology GmbH.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardiovascular Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Symetis SA.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lepu Medical Technology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jude Medical (now part of Abbott).
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AtriCure, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vascular Solutions, Inc.
- Biotronik SE & Co. KG.
- Cook Medical
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
2025-2033 年经导管肺动脉瓣市场（按技术、原料、应用、最终用户和地区划分）
经导管主动脉瓣置换术市场规模、份额、趋势分析报告：按植入程序、材料、机制、最终用途、地区、细分预测，2025-2030 年
美国经导管栓塞和封堵 (TEO) 设备市场：Medtech 360
亚太地区经导管栓塞和封堵 (TEO) 设备市场：Medtech 360
欧洲经导管栓塞和封堵 (TEO) 设备市场：Medtech 360
经导管器材市场规模、份额和趋势分析报告：2025-2030 年按产品、应用、地区和细分市场进行的预测
经导管器材市场：按产品、按应用划分 - 2025-2030 年全球预测
经导管栓塞和阻塞设备市场：按产品、应用和最终用户划分 - 全球预测 2025-2030 年
经导管肺动脉瓣市场：按技术、原材料、应用和最终用途分类 - 全球预测 2025-2030
全球经导管肺动脉瓣市场 (2024-2028)